Myelodysplastic Syndrome Drugs Market 2030: The Importance of Early Diagnosis
The global myelodysplastic syndrome drugs market size is expected to reach USD 5.28 billion by 2030, exhibiting at a CAGR of 9.1% from 2024 to 2030, according [read full press release…]
